Veratrak’s CEO, Jason Lacombe, shared the podium with experts from IBM to discuss “Blockchain In Action”. More than 400 people attended the conference on November the 18th of 2019, where approximately 90 speakers shared a wealth of experience over two days of sessions. The interactive sessions covered a range of topics, from operations and manufacturing, to technology and collaboration. Communications amongst stakeholders in the pharmaceutical industry was the overarching theme of the conference. A majority of the speakers acknowledged the need for improved collaboration technologies. Veratrak’s CEO, Jason Lacombe, shared the podium with experts from IBM for a talk titled “Blockchain In Action”. During the session, an overview of blockchain was given, along with practical use cases for the technology. Key takeaways from the session: Collaboration between life sciences companies requires processes around how information is shared. Blockchain provides a secure and compliant method for sharing information among different stakeholders in the life science supply chain facilitated by its immutable audit logs. Whilst organisations have document management tools…
Business operations in many industries have had to adapt to restrictions in place to curb the spread of Covid-19. While some operations can be paused until it is safe to resume normal practices, like working alongside colleagues or in-person trade shows, for many of the world’s critical industries, customers and suppliers must carry on communicating and collaborating. GxP manufacturing in the pharmaceutical industry has had to adjust to meet the challenges Covid-19 poses. The pharmaceutical supply chain, continuing to develop, test, manufacture, and ship medicine across borders around the world, has to ensure rigorous quality for these processes now, more than ever. To ensure this quality is achieved, supplier audits are performed both when on-boarding a new supplier and then periodically to track continued quality over time. These audits traditionally take place in-person, with customers visiting their suppliers (often across continents) to view manufacturing operations and review quality documentation, certificates, and process documents. With ongoing travel restrictions, pharmaceutical companies have had to quickly pivot to carrying out remote…
We were delighted to be part of the Oxford Saïd Entrepreneurship Forum at the Oxford Saïd Business School. On 3rd March 2018, the Veratrak leadership team attended OSEF, a forum for entrepreneurship in Oxford. The day featured a wide range of interesting topics, from interviews with successful serial entrepreneurs, discussions on HealthTech and the funding landscape in Europe. The day concluded with a series of talks from companies using innovative approaches. Veratrak CEO Jason Lacombe, spoke as part of this. He presented attendees with a frank look at issues faced in the pharmaceutical supply chain with security and collaboration. He then spoke about how Veratrak is solving those problems for our customers. Jason Presenting to Crowd at OSEF It was great to be involved in the Oxford Saïd Entrepreneurship Forum..
As part of a joint event between the Oxford Foundry and the Oxford University Blockchain Society, Veratrak CEO, Jason Lacombe discussed with fellow experts "How Blockchain Will Radically Change our Society". The event was billed as "an evening conversation about what Blockchain is capable of doing, and how it will transform business, work, governance and society." and Jason was involved in some in depth discussion with the other experts on the panel. The panel comprised of: Jack Laing, Oxford University Blockchain Society President (Chair)Ludwig Siegele, Technology Editor at The EconomistRuth Milligan, Head of Financial Services & Payments Programme at Tech UKJason Lacombe, CEO at VeratrakProfessor Vili Lehdonvirta, Associate Professor and Senior Research Fellow at the Oxford Internet Institute Discussion topics ranged from Decentralised Autonomous Organisations (DAOs), to the implications of immutability for data privacy. The panel was followed by a networking session with many more questions and interesting discussion on how Veratrak is practically solving problems within the pharmaceutical supply chain. Audience at Oxford Foundry Panel
In a detailed landscape analysis examining the UK blockchain ecosystem both Veratrak and CEO, Jason Lacombe, were identified as key influencers. The report was led by the All Party Parliamentary Group on Blockchain, as well as, the Big Innovation Centre, Deep Knowledge Analytics, and DAG Global. The report highlights that the UK is increasingly being viewed on a global scale as a hub for blockchain activities, and investments in UK-backed blockchain companies continues to rise. At Veratrak, we are thrilled to be featured in this report which presents an in-depth analysis of 225 companies, 180 investors and 30 tech hubs and is the most robust analysis of the UK blockchain ecosystem to date.
We were thrilled to be invited to talk at Pharmapack Europe 2018 about what Veratrak is doing to drive innovation in the pharmaceutical supply chain. On 7th February 2018, Veratrak CEO Jason Lacombe, spoke to conference attendees about issues faced with security and collaboration with supply chain partners, educated attendees on the huge benefits that blockchain technology can bring to this problem, and spoke about our pilot projects and vision.
Veratrak is honoured to have won the prestigious Oxford University "Innovation of the Year" Award. This annual competition highlights the best and most promising of the University's innovative businesses. The award consists of a significant cash prize, follow-on investment opportunities, and ongoing mentorship from some members of the expert judging panel. Facing stiff competition from over 30 Oxford based companies, Veratrak was selected as the winner by an expert panel including Gerald Chan. Veratrak presenting to the crowd at the tri-innovate event.
From Tuesday October 9th - Thursday October 11th members of the Veratrak team were in attendance at CPHI in Madrid. This annual global conference is the largest gathering of pharmaceutical professionals in the world, and attended by over 45,000 industry people and 2,500 companies exhibiting. It was great to have the opportunity to speak with so many companies, and understand the ways in which they collaborate on documentation. We are excited to continue to work with, and explore opportunities with these companies.
Veratrak is excited to announce that they are a founding member of the European Platform on Changing Healthcare (EPOCH). This is the First European Blockchain Working Group for the Pharmaceutical Industry. EPOCH is an industry-specific technology working group that brings together pharmaceutical supply chain executives, emerging technologies thought leaders, standards agencies and 3rd party consultants/innovation groups. With interactive collaboration, the platform aims to: create dialogue about the future of the industry for adopting innovative technologies, produce industry papers outlining recommendations and a roadmap to adopting a more lean and secure pharmaceutical supply chain, and educate about the capabilities of blockchain using a pragmatic and hypothesis-driven approach.To learn more and become a member visit www.epoch-group.org or follow EPOCH on Twitter @theEPOCHgroup.
We were honoured to take part in a Silicon Valley Healthcare Innovation Day hosted by Plug and Play in Sunnyvale California. It was great to have the opportunity to speak to a wide variety of healthcare innovators, and to take inspiration from the other companies presenting. https://www.youtube.com/embed/K1OBJV72YbI